Market Tracker

11/21 6:05pm ET

Ocata Therapeutics Inc (OTCQB:OCAT)

6.20
Data as of Nov 21
 -0.18 / -2.82%
Today’s Change
4.95
Today|||52-Week Range
12.73
+0.49%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close6.38
Today’s open6.40
Day’s range6.20 - 6.41
Volume93,109
Average volume (3 months)229,412
Market cap$213.2M
Dividend yield--
Data as of 4:01pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-51.77%
P/E ratioNM
Price/Sales683.37
Price/Book14.26

Competitors

No competitors data available.

Financials

Last reporting dateNovember 24, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$225.0K
Annual profit (last year)-$31.0M
Net profit margin-13,788.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts